Predicting Toxicity in Elderly Patients With Head and Neck Cancer

Effect of Prehabilitation on Head and Neck Cancer Patients

NCT06593639 ·Status: RECRUITING ·Phase: NA

Induction Chemotherapy for Advanced Head and Neck Cancer

NCT00959387 ·Status: COMPLETED ·Phase: PHASE2

Head and Neck Cancer Survivorship Ototoxicity Screening (SOS)

NCT05789316 ·Status: COMPLETED ·Phase: NA

Health and Economic Outcomes of Two Different Follow up Strategies in Effectively Cured Advanced Head and Neck Cancer

NCT02262221 ·Status: SUSPENDED ·Phase: NA

Use of Computer-based Patient-reported Data to Assess Long Term and Late Effects of Head and Neck Cancer at the Point-of-care

NCT01803061 ·Status: COMPLETED ·Phase: NA

Quick Diagnostic Program for Head and Neck Cancer

NCT02030509 ·Status: COMPLETED

Detection in Peripheral Blood of Circulating Tumor Cells in Patient With Head and Neck Squamous Cell Carcinoma

NCT02892786 ·Status: COMPLETED ·Phase: NA

Efficacy and Toxicity of Docetaxel as a Radiosenstizer in Head and Neck Cancer

NCT06360978 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Observational Study on Biomarkers in Head and Neck Cancer (HNprädBio)

NCT02059668 ·Status: COMPLETED

Study of a Simplified Geriatric Evaluation Performed by Oncologists Prior to Cancer Treatment by Radiotherapy or Chemotherapy in Subjects Aged 70 Years or Older With Inoperable Squamous Cell Cancer of the Head and Neck

NCT03614936 ·Status: UNKNOWN

Treatment of Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck

NCT01086826 ·Status: COMPLETED ·Phase: PHASE3

The Clinical Study of the Poorly Differentiated Head and Neck Squamous Cell Carcinoma

NCT02916368 ·Status: UNKNOWN

Value of Geriatric Screening to Predict Postoperative Morbidity for Head and Neck Cancer

NCT03053310 ·Status: ACTIVE_NOT_RECRUITING

Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy

NCT05337631 ·Status: RECRUITING

AIOCC Italian Registry on Head and Neck Carcinomas

NCT06248944 ·Status: RECRUITING

A Phase II Study to Evaluate the Efficacy and Safety of Salvage Preoperative PD-1 Inhibitor Combined with Chemotherapy Neoadjuvant Therapy in Recurrent and Metastatic LPSCC/HPSCC

NCT06793761 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Efficacy and Safety of PD-1 Plus Chemotherapy in Poorly Differentiated Locally Advanced (LA) HNSCC

NCT06100497 ·Status: RECRUITING ·Phase: PHASE2

Concurent Chemoradiotherapy in Head and Neck Cancers

NCT04780750 ·Status: UNKNOWN ·Phase: PHASE3

Predictors of Acute Toxicity and Flap Failure After Adjuvant Treatment for Locally Advanced Head and Neck Cancer

NCT06661265 ·Status: NOT_YET_RECRUITING

Hypofractionated Radiotherapy and Concurrent Cisplatin for Head and Neck Cancer

NCT03194061 ·Status: UNKNOWN ·Phase: NA

Feasibility and Tolerance of Nivolumab Neoadjuvant Immunotherapy in High Risk HPV Driven Oropharynx Cancer

NCT03838263 ·Status: COMPLETED ·Phase: PHASE2

Low-Dose Weekly vs High-Dose Cisplatin

NCT03649048 ·Status: RECRUITING ·Phase: NA

Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Treatment and Outcome

NCT06380686 ·Status: RECRUITING

Docetaxel in Head and Neck Cancer

NCT00261703 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Comparing Neoadjuvant Chemotherapy Combined With PD-1 Inhibitor Versus Neoadjuvant Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Carcinoma

NCT06957938 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3